Stress-induced anhedonia correlates with lower hippocampal serotonin transporter protein expression

Brain Research

Volumn 1513, Issue , 2013, Pages 127-134

  Tang, Man ^a   Lei, Jieyu ^a   Sun, Xiao ^b   Liu, Guojun ^a   Zhao, Shulei ^c  

^a CHINA MEDICAL UNIVERSITY   (China)

^b SHENYANG MEDICAL COLLEGE   (China)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Anhedonia; Fluoxetine; Hippocampus; Serotonin transporter; Sucrose preference; Unpredictable chronic mild stress

Indexed keywords

FLUOXETINE; SEROTONIN TRANSPORTER; SUCROSE; SEROTONIN UPTAKE INHIBITOR;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DEPRESSION; DETERIORATION; DOWN REGULATION; DRUG EFFICACY; ENDOPHENOTYPE; GROOMING; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRESS; TREATMENT DURATION; WEIGHT CHANGE; ANALYSIS OF VARIANCE; ANIMAL; DISEASE MODEL; DRUG EFFECTS; DRUG THERAPY; FOOD PREFERENCE; GENE EXPRESSION REGULATION; MENTAL STRESS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; STATISTICS; TIME;

MUS;

ANALYSIS OF VARIANCE; ANHEDONIA; ANIMALS; BODY WEIGHT; DISEASE MODELS, ANIMAL; FLUOXETINE; FOOD PREFERENCES; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; MICE; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; STATISTICS AS TOPIC; STRESS, PSYCHOLOGICAL; SUCROSE; TIME FACTORS;

EID: 84877604937     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2013.03.042     Document Type: Article

References (38)

1. O. Berton, and E.J. Nestler New approaches to antidepressant drug discovery: beyond monoamines Nat. Rev. Neurosci. 7 2006 137 151
2. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Chem. 72 1976 248 254
3. A. Caspi, K. Sugden, T.E. Moffitt, A. Taylor, I.W. Craig, H. Harrington, J. McClay, J. Mill, J. Martin, A. Braithwaite, and R. Poulton Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene Science 301 2003 386 389
4. D. Chaudhury, J.J. Walsh, A.K. Friedman, B. Juarez, S.M. Ku, J.W. Koo, D. Ferguson, H.C. Tsai, L. Pomeranz, D.J. Christoffel, A.R. Nectow, M. Ekstrand, A. Domingos, M.S. Mazei-Robison, E. Mouzon, M.K. Lobo, R.L. Neve, J.M. Friedman, S.J. Russo, K. Deisseroth, E.J. Nestler, and M.H. Han Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons Nature 493 2013 532 536
5. A. Daniele, R. Divella, A. Paradiso, V. Mattioli, F. Romito, F. Giotta, P. Casamassima, and M. Quaranta Serotonin transporter polymorphism in major depressive disorder (MDD), psychiatric disorders, and in MDD in response to stressful life events: causes and treatment with antidepressant In Vivo 25 2011 895 901
6. D.J. David, C.E. Renard, P. Jolliet, M. Hascoet, and M. Bourin Antidepressant-like effects in various mice strains in the forced swimming test Psychopharmacology 166 2003 373 382
7. C. Ducottet, G. Griebel, and C. Belzung Effects of the selective nonpeptide corticotropin-releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice Prog. Neuropsychopharmacol. Biol. Psychiatry 27 2003 625 631
8. C.H. Duman Models of depression Vitam. Horm. 82 2010 1 21
9. N. Elizalde, F.J. Gil-Bea, M.J. Ramirez, B. Aisa, B. Lasheras, J. Del Rio, and R.M. Tordera Long-lasting behavioral effects and recognition memory deficit induced by chronic mild stress in mice: effect of antidepressant treatment Psychopharmacology 199 2008 1 14
10. J.A. Gingrich, and R. Hen The broken mouse: the role of development, plasticity and environment in the interpretation of phenotypic changes in knockout mice Curr. Opin. Neurobiol. 10 2000 146 152
11. G. Grecksch, D. Zhou, C. Franke, U. Schroder, B. Sabel, A. Becker, and G. Huether Influence of olfactory bulbectomy and subsequent imipramine treatment on 5-hydroxytryptaminergic presynapses in the rat frontal cortex: behavioural correlates Br. J. Pharmacol. 122 1997 1725 1731
12. S. Iritani, M. Tohgi, T. Arai, and K. Ikeda Immunohistochemical study of the serotonergic neuronal system in an animal model of the mood disorder Exp. Neurol. 201 2006 60 65
13. E. Isingrini, C. Belzung, J.L. Freslon, M.C. Machet, and V. Camus Fluoxetine effect on aortic nitric oxide-dependent vasorelaxation in the unpredictable chronic mild stress model of depression in mice Psychosom. Med. 74 2012 63 72
14. J.W. Jahng, J.G. Kim, H.J. Kim, B.T. Kim, D.W. Kang, and J.H. Lee Chronic food restriction in young rats results in depression- and anxiety-like behaviors with decreased expression of serotonin reuptake transporter Brain Res. 1150 2007 100 107
15. R.C. Kessler, P. Berglund, O. Demler, R. Jin, D. Koretz, K.R. Merikangas, A.J. Rush, E.E. Walters, and P.S. Wang The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) JAMA 289 2003 3095 3105
16. V. Krishnan, M.H. Han, D.L. Graham, O. Berton, W. Renthal, S.J. Russo, Q. Laplant, A. Graham, M. Lutter, D.C. Lagace, S. Ghose, R. Reister, P. Tannous, T.A. Green, R.L. Neve, S. Chakravarty, A. Kumar, A.J. Eisch, D.W. Self, F.S. Lee, C.A. Tamminga, D.C. Cooper, H.K. Gershenfeld, and E.J. Nestler Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions Cell 131 2007 391 404
17. V. Krishnan, and E.J. Nestler The molecular neurobiology of depression Nature 455 2008 894 902
18. I. Lucki, A. Dalvi, and A.J. Mayorga Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice Psychopharmacology 155 2001 315 322
19. R.T. Malison, E. McCance, L.L. Carpenter, R.M. Baldwin, J.P. Seibyl, L.H. Price, T.R. Kosten, and R.B. Innis [123I]beta-CIT SPECT imaging of dopamine transporter availability after mazindol administration in human cocaine addicts Psychopharmacology 137 1998 321 325
20. C.J. Murry, and A.D. Lopez Alternative projections of mortality and disability by cause 1990-2020 Lancet 349 1997 1498 1504
21. A.B. Newberg, J.D. Amsterdam, N. Wintering, K. Ploessl, R.L. Swanson, J. Shults, and A. Alavi 123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study J. Nucl. Med. 46 2005 973 977
22. A.B. Newberg, J.D. Amsterdam, N. Wintering, and J. Shults Low brain serotonin transporter binding in major depressive disorder Psychiatry Res. 202 2012 161 167
23. D.D. Pollak, C.E. Rey, and F.J. Monje Rodent models in depression research: classical strategies and new directions Ann. Med. 42 2010 252 264
24. S. Pothion, J.C. Bizot, F. Trovero, and C. Belzung Strain differences in sucrose preference and in the consequences of unpredictable chronic mild stress Behav. Brain Res. 155 2004 135 146
25. M. Reimold, A. Batra, A. Knobel, M.N. Smolka, A. Zimmer, K. Mann, C. Solbach, G. Reischl, F. Schwärzler, G. Gründer, H.J. Machulla, R. Bares, and A. Heinz Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET study Mol. Psychiatry 13 606-613 2008 557
26. N. Ripoll, D.J. David, E. Dailly, M. Hascoet, and M. Bourin Antidepressant-like effects in various mice strains in the tail suspension test Behav. Brain Res. 143 2003 193 200
27. A. Sahay, and R. Hen Adult hippocampal neurogenesis in depression Nat. Neurosci. 10 2007 1110 1115
28. J.B. Savitz, and W.C. Drevets Neuroreceptor imaging in depression Neurobiol. Dis. 2012 [Epub ahead of print]
29. J.L. Scholl, K.J. Renner, G.L. Forster, and S. Tejani-Butt Central monoamine levels differ between rat strains used in studies of depressive behavior Brain Res. 1355 2010 41 51
30. J. Stemmelin, C. Cohen, I. Yalcin, P. Keane, and G. Griebel Implication of beta3-adrenoceptors in the antidepressant-like effects of amibegron using Adrb3 knockout mice in the chronic mild stress Behav. Brain Res. 206 2010 310 312
31. T. Strekalova, N. Gorenkova, E. Schunk, O. Dolgov, and D. Bartsch Selective effects of citalopram in a mouse model of stress-induced anhedonia with a control for chronic stress Behav. Pharmacol. 17 2006 271 287
32. M.H. Trivedi, A.J. Rush, S.R. Wisniewski, A.A. Nierenberg, D. Warden, L. Ritz, G. Norquist, R.H. Howland, B. Lebowitz, P.J. McGrath, K. Shores-Wilson, M.M. Biggs, G.K. Balasubramani, and M. Fava Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice Am. J. Psychiatry 163 2006 28 40
33. K.M. Tye, J.J. Mirzabekov, M.R. Warden, E.A. Ferenczi, H.C. Tsai, J. Finkelstein, S.Y. Kim, A. Adhikari, K.R. Thompson, A.S. Andalman, L.A. Gunaydin, I.B. Witten, and K. Deisseroth Dopamine neurons modulate neural encoding and expression of depression-related behaviour Nature 493 2013 537 541
34. Y. Wang, F. Yang, Y.F. Liu, F. Gao, and W. Jiang Acetylsalicylic acid as an augmentation agent in fluoxetine treatment resistant depressive rats Neurosci. Lett. 499 2011 74 79
35. C.L. Wellman, A. Izquierdo, J.E. Garrett, K.P. Martin, J. Carroll, R. Millstein, K.P. Lesch, D.L. Murphy, and A. Holmes Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice J. Neurosci. 27 2007 684 691
36. Q. Xiao, A. Pawlyk, and S.M. Tejani-Butt Reserpine modulates serotonin transporter mRNA levels in the rat brain Life Science 64 1999 63 68
37. H.C. Yan, X. Cao, M. Das, X.H. Zhu, and T.M. Gao Behavioral animal models of depression Neurosci. Bull. 26 2010 327 337
38. S. Zhao, J. Edwards, J. Carroll, L. Wiedholz, R.A. Millstein, C. Jiang, D.L. Murphy, T.H. Lanthorn, and A. Holmes Insertion mutation at the C-terminus of the serotonin transporter disrupts brain serotonin function and emotion-related behaviors in mice Neuroscience 140 2006 321 334